[3-(4-chloro-2-fluorophenyl)-5-(5-propan-2-yltetrazol-1-yl)phenyl] N-[(2R)-1-methoxypropan-2-yl]carbamate
C21H23ClFN5O3 — CID 122505921
Data last refreshed: (MolForge compound catalog, from PubChem)
About [3-(4-chloro-2-fluorophenyl)-5-(5-propan-2-yltetrazol-1-yl)phenyl] N-[(2R)-1-methoxypropan-2-yl]carbamate
[3-(4-chloro-2-fluorophenyl)-5-(5-propan-2-yltetrazol-1-yl)phenyl] N-[(2R)-1-methoxypropan-2-yl]carbamate (PubChem CID 122505921) has the molecular formula C21H23ClFN5O3 and a molecular weight of 447.90 g/mol. Its IUPAC name is [3-(4-chloro-2-fluorophenyl)-5-(5-propan-2-yltetrazol-1-yl)phenyl] N-[(2R)-1-methoxypropan-2-yl]carbamate.
Molecular Properties
| Compound Name | [3-(4-chloro-2-fluorophenyl)-5-(5-propan-2-yltetrazol-1-yl)phenyl] N-[(2R)-1-methoxypropan-2-yl]carbamate |
|---|---|
| PubChem CID | 122505921 |
| Molecular Formula | C21H23ClFN5O3 |
| Molecular Weight | 447.90 g/mol |
| Exact Mass | 447.15 |
| IUPAC Name | [3-(4-chloro-2-fluorophenyl)-5-(5-propan-2-yltetrazol-1-yl)phenyl] N-[(2R)-1-methoxypropan-2-yl]carbamate |
| SMILES | COC[C@@H](C)NC(=O)Oc1cc(-c2ccc(Cl)cc2F)cc(-n2nnnc2C(C)C)c1 |
| InChI | InChI=1S/C21H23ClFN5O3/c1-12(2)20-25-26-27-28(20)16-7-14(18-6-5-15(22)9-19(18)23)8-17(10-16)31-21(29)24-13(3)11-30-4/h5-10,12-13H,11H2,1-4H3,(H,24,29)/t13-/m1/s1 |
| InChIKey | BKIBOSVLMQQYHY-CYBMUJFWSA-N |
| XLogP | 4.37 |
| TPSA | 91.16 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 447.90 |
| LogP ≤ 5 | 4.37 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122505921 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.